Literature DB >> 15170916

Variability of precision in scoring radiographic abnormalities in rheumatoid arthritis by experienced readers.

John T Sharp1, Frederick Wolfe, Marissa Lassere, Maarten Boers, Désirée Van Der Heijde, Arvi Larsen, Harold Paulus, Rolf Rau, Vibeke Strand.   

Abstract

OBJECTIVE: To determine the extent of precision and sources of variability among experts on scoring radiographic abnormalities in rheumatoid arthritis.
METHODS: Radiographic scores from 6 datasets in which 2 or more readers had scored film sets were analyzed. Datasets included scores by 11 different readers, 6 of whom scored films by both the Larsen (global) and Sharp (composite) methods. Scores of each possible combination of 2 readers were compared in calculating the smallest detectable difference (SDD) on raw scores and on scores normalized for each individual reader (nSDD). Intraclass correlation (ICC), Pearson's r, and the correlation between differences in score and their mean scores were determined. Agreement on progression of radiographic damage scores was also examined.
RESULTS: Variability among readers was greater than previous studies suggested. Agreement was better for intra- than interreader comparisons; average intrareader SDD was 24.4 for the composite method and 9.0 for the global. The larger SDD for the composite method reflect their greater range of possible scores. When normalized scores were used to adjust for the range difference, there was minimal difference in the SDD; nSDD was 10.1 for the composite method, 8.0 for the global. Interreader variability was larger: SDD of 53.7 for the composite method and 23.3 for the global; nSDD 12.9 and 14.4, respectively. ICC varied between 0.465 and 0.999, with all but one value below 0.925 occurring in composite scores with a range below 100. Differences in repeated scores were frequently associated with the mean of those scores and this was greater for inter- than for intrareader comparisons. Agreement between progression scores showed a similar pattern. The SDD was better for intrareader comparisons and smaller for global scores: compare 13.7 (composite, intrareader) and 5.4 (global, intrareader) to 18.1 (composite, interreader) and 8.7 (global, interreader). The ICC was lower for progression scores than for raw scores, averaging between 0.661 and 0.885.
CONCLUSION: The variability in scoring radiographic abnormalities is considerable among this group of 11 expert readers. This has important implications for power calculations in comparison studies such as therapeutic trials and for cross-trial comparisons. The correlation between the difference in repeated scores and their means indicates systematic error (bias), which, if corrected, may improve the detection of treatment effects when using a responder-type analysis. These and other design and analysis issues are discussed.

Entities:  

Mesh:

Year:  2004        PMID: 15170916

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  18 in total

1.  Use of digital x ray radiogrammetry in the assessment of joint damage in rheumatoid arthritis.

Authors:  W B Jawaid; D Crosbie; J Shotton; D M Reid; A Stewart
Journal:  Ann Rheum Dis       Date:  2005-08-26       Impact factor: 19.103

Review 2.  Reporting of radiographic methods in randomised controlled trials assessing structural outcomes in rheumatoid arthritis.

Authors:  Gabriel Baron; Isabelle Boutron; Bruno Giraudeau; Philippe Ravaud
Journal:  Ann Rheum Dis       Date:  2006-12-11       Impact factor: 19.103

Review 3.  [Quantitative imaging in rheumatoid arthritis: from scoring to measurement].

Authors:  P Peloschek; G Langs; A Valentinitsch; M Bubale; T Schlager; C Müller-Mang; F Kainberger
Journal:  Radiologe       Date:  2006-05       Impact factor: 0.635

Review 4.  [Measurement instead of scoring in rheumatology: new quantitative imaging and processing methods in radiology].

Authors:  P Peloschek; C Müller-Mang; K Friedrich; G Langs; R Donner; A Valentinitsch; F Kainberger
Journal:  Z Rheumatol       Date:  2008-02       Impact factor: 1.372

5.  A reliability study using computer-based analysis of finger joint space narrowing in rheumatoid arthritis patients.

Authors:  Katsuya Hatano; Tamotsu Kamishima; Kenneth Sutherland; Masaru Kato; Ikuma Nakagawa; Shota Ichikawa; Keisuke Kawauchi; Shota Saitou; Masaya Mukai
Journal:  Rheumatol Int       Date:  2016-10-28       Impact factor: 2.631

6.  Equivalent responses to disease-modifying antirheumatic drugs initiated at any time during the first 15 months after symptom onset in patients with seropositive rheumatoid arthritis.

Authors:  Haoling H Weng; Veena K Ranganath; Dinesh Khanna; Myungshin Oh; Daniel E Furst; Grace S Park; David A Elashoff; John T Sharp; Richard H Gold; James B Peter; Harold E Paulus
Journal:  J Rheumatol       Date:  2010-01-28       Impact factor: 4.666

7.  Semi-Automated Quantification of Finger Joint Space Narrowing Using Tomosynthesis in Patients with Rheumatoid Arthritis.

Authors:  Shota Ichikawa; Tamotsu Kamishima; Kenneth Sutherland; Hideki Kasahara; Yuka Shimizu; Motoshi Fujimori; Nobutoshi Yasojima; Yohei Ono; Takahiko Kaneda; Takao Koike
Journal:  J Digit Imaging       Date:  2017-06       Impact factor: 4.056

8.  Validation of Fully Automatic Quantitative Software for Finger Joint Space Narrowing Progression for Rheumatoid Arthritis Patients.

Authors:  Chiaki Narisawa; Kenneth Sutherland; Yutong Lu; Akira Furusaki; Akira Sagawa; Tamotsu Kamishima
Journal:  J Digit Imaging       Date:  2020-09-28       Impact factor: 4.056

9.  The role of biologic agents in damage progression in rheumatoid arthritis: indirect comparison of data coming from randomized clinical trials.

Authors:  Ennio Giulio Favalli; Francesca Pregnolato; Martina Biggioggero; Pier Luigi Meroni
Journal:  Ther Adv Musculoskelet Dis       Date:  2012-08       Impact factor: 5.346

10.  The prognostic value of baseline erosions in undifferentiated arthritis.

Authors:  Mohamed M Thabet; Thomas W J Huizinga; Désirée M van der Heijde; Annette H M van der Helm-van Mil
Journal:  Arthritis Res Ther       Date:  2009-10-15       Impact factor: 5.156

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.